Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil.

Article Details

Citation

Sarges R, Bordner J, Dominy BW, Peterson MJ, Whipple EB

Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil.

J Med Chem. 1985 Nov;28(11):1716-20.

PubMed ID
3934383 [ View in PubMed
]
Abstract

The aldose reductase inhibitor 2,3-dihydro-6-fluorospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5 '-dione was resolved into its enantiomers. Sorbinil, the S isomer, was found to be a better inhibitor of the enzyme in vitro and in vivo than the corresponding R isomer. X-ray data on sorbinil, which were used to determine its absolute configuration, are presented. NMR studies of sorbinil in solution indicate the existence of two conformers with a low energy barrier for interconversion.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
SorbinilAldose reductaseIC 50 (nM)1000N/AN/ADetails
SorbinilAldose reductaseIC 50 (nM)150N/AN/ADetails
SorbinilAldose reductaseIC 50 (nM)4400N/AN/ADetails
SorbinilAldose reductaseIC 50 (nM)20000N/AN/ADetails